Our Team
Dr. Mercedes Kweh, MSL-cert., MSc., PhD.
Founder and CEO
Mercedes is an accomplished and versatile leader with a wealth of expertise in the development of medical and commercial strategies, pre-clinical and clinical trial design, regulatory pathways to drug development, and more. With a background as a seasoned Medical Research Immunologist and nearly 20 years of experience, she brings a comprehensive approach to her work at KweHealth.
Throughout her impressive career, Mercedes has demonstrated proficiency in overseeing clinical trial operations, authoring proposals and manuscripts, fostering collaborations with Key Opinion Leaders (KOLs) and other Healthcare Professionals (HCPs), and ensuring regulatory compliance. Her diverse skill set, including degrees, certifications, and extensive experience, enables her to excel across various specialties such as immunology, oncology, cardiovascular, chronic inflammation, and infectious diseases.
Mercedes possesses several key competencies that greatly beneficial in meeting our client’s goals. She excels in building and nurturing relationships with stakeholders, effectively communicating complex scientific concepts to diverse audiences, consistently delivering high-quality results within strict timelines, managing individual and team performance, and utilizing critical thinking skills to develop effective medical and commercial strategies. With Mercedes at the helm, KweHealth is exceptionally well-equipped to help organizations achieve their goals and targets.
Mercedes's expertise, drive, and dedication to excellence make her an invaluable asset to KweHealth and our clients. Her leadership os Chief Executive Officer ensures that the company remains at the forefront of industry advancements, consistently delivering outstanding results and maintaining the highest standards of quality and compliance.
"I believe that the intersection of science, strategy, and compliance is where true innovation and progress thrive. By navigating the complex landscape of medical research and regulatory pathways with unwavering dedication, we can bring transformative solutions to patients and healthcare organizations alike.”
Dr. Frederick A. Kweh, PhD.
Founder and CTSO
Fred is an accomplished biotechnology professional with over 20 years of expertise in basic and translational research. His unwavering passion for scientific exploration has consistently pushed the boundaries of biotechnology and made significant contributions to the advancement of medical science. With a strong background in laboratory research and a proven track record of leading teams of scientists, Fred brings a wealth of experience and knowledge to his role as the Chief Technology and Scientific Officer at KweHealth.
Fred's primary objective is to refine and expand our client’s capabilities in product research, development, characterization, and manufacturing. He is deeply committed to exploring new and innovative approaches that enhance your company’s understanding and application of biotechnology. Leveraging his extensive expertise in basic and translational research, Fred is determined to develop next-generation fit-for-purpose analytical tools that will revolutionize the development and manufacturing processes of vaccines, gene therapies, and protein therapies within our client’s facilities. Through these advancements, he also aims to enhance safety, efficacy, production yields, and affordability in these critical areas.
Throughout his distinguished career, Fred has consistently demonstrated a strong commitment to innovation and quality by design. By remaining at the forefront of technology development in the biomanufacturing industry, he has played a pivotal role in helping companies maintain their competitive edge. With a firm belief in the transformative power of continuous innovation and a focus on quality, Fred envisions revolutionizing the biotechnology industry and contributing to the betterment of healthcare on a global scale.
"I firmly believe that through continuous innovation and a steadfast commitment to quality, we can drive a remarkable revolution in the biotechnology industry and make significant contributions to improving healthcare worldwide."